NFKB1 and neoplasm: Activation of nuclear transcription factor (NFkB) can promote the transcription of apoptotic genes, leading to the proliferation of tumor cells, and affect the sensitivity of tumor cells to chemotherapy and the prognosis of patients 39-41.